Article info
Ovarian Cancer
Debulking Surgery and Intraperitoneal Chemotherapy Are Associated With Decreased Morbidity in Women Receiving Neoadjuvant Chemotherapy for Ovarian Cancer
- Address correspondence and reprint requests to William Robinson, MD, Tulane University School of Medicine, 1430 Tulane Ave, SL-11, New Orleans, LA 70112. E-mail: wrobinso{at}tulane.edu.
Citation
Debulking Surgery and Intraperitoneal Chemotherapy Are Associated With Decreased Morbidity in Women Receiving Neoadjuvant Chemotherapy for Ovarian Cancer
Publication history
- Received April 17, 2013
- Accepted August 22, 2013
- First published January 1, 2014.
Online issue publication
January 01, 2014
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2013 by IGCS and ESGO